Childhood Cancer Data Initiative Annual Symposium (Abstract Registration): Submission #33

serial: '33'
sid: '146944'
uuid: 2a2df9d6-ae2e-489c-a13a-5c1caa131bb5
uri: /nci/ccdisymposium/abstract
created: '1752774091'
completed: '1752774254'
changed: '1752774254'
in_draft: '0'
current_page: ''
remote_addr: 10.208.24.104
uid: '0'
langcode: en
webform_id: ccdi_symposium_abstract
entity_type: node
entity_id: '2139'
locked: '0'
sticky: '0'
notes: ''
metatag: meta
data:
  authors_:
    - add_author_degree: PhD
      add_author_first_name: Liya
      add_author_last_name: Xu
      add_author_middle: ''
      add_author_organization: "Children's Hospital Los Angeles"
    - add_author_degree: MD
      add_author_first_name: 'Laura '
      add_author_last_name: Kagami
      add_author_middle: ''
      add_author_organization: "Children's Hospital Los Angeles"
    - add_author_degree: PhD
      add_author_first_name: Venkata
      add_author_last_name: Yellapnatula
      add_author_middle: ''
      add_author_organization: "Children's Hospital Los Angeles"
    - add_author_degree: Master
      add_author_first_name: Nerea
      add_author_last_name: Goni
      add_author_middle: ''
      add_author_organization: 'University of Southern California'
    - add_author_degree: MD
      add_author_first_name: Jaclyn
      add_author_last_name: Biegel
      add_author_middle: ''
      add_author_organization: "Children's Hospital Los Angeles"
    - add_author_degree: MD
      add_author_first_name: Jesse
      add_author_last_name: Berry
      add_author_middle: ''
      add_author_organization: "Children's Hospital Los Angeles"
  abstract: |-
    Background: Retinoblastoma (RB), the most common intraocular malignancy in children, laid the foundation for cancer genetics through the discovery of the RB1 tumor suppressor gene and the "two-hit" hypothesis. However, precision oncology has largely bypassed RB due to the risks associated with intraocular tumor biopsy. To overcome this, we developed an aqueous humor (AH) liquid biopsy platform for genomic profiling using tumor-derived cell-free DNA (cfDNA).

    Methods: We established LBSeq4Kids, a CLIA-certified laboratory-developed test combining low-pass whole genome sequencing (LP-WGS) for detecting somatic copy number alterations (CNAs) and a custom pediatric targeted sequencing panel (TSP) for single nucleotide variants and fusions. A total of 147 AH samples from 60 patients (75 eyes) with suspected intraocular malignancy were analyzed.

    Results: In 41 RB patients, LP-WGS detected CNAs in 94% of diagnostic samples and 100% of recurrent cases, achieving an overall sensitivity of 97%. No CNAs or pathogenic variants were detected in 14 patients with benign mimickers, demonstrating 100% specificity. Serial testing showed CNA clearance in 61% of eyes after two treatment cycles, aligning with clinical remission. TSP identified RB1 mutations in 92% of germline variant cases and was valuable in CNA-negative tumors.

    Conclusions: LBSeq4Kids enables safe, repeatable molecular profiling in RB, transforming it into a genomically accessible cancer. This approach offers precise diagnosis, risk assessment, treatment monitoring, and recurrence detection, marking a significant advance in pediatric precision oncology.
  abstract_file: ''
  abstract_title_: 'Aqueous Humor Liquid Biopsy Enables Molecular Diagnosis and Monitoring in Retinoblastoma'
  email_address_: liyaxu@usc.edu
  institution_: "Children's Hospital Los Angeles"
  presenting_author_: 'Liya Xu'